T10B9 action: the effect of anti-T-cell antibody mitogenicity and graft rejection on the first dose cytokine response.
Brown
S
S
University of Kentucky Department of Internal Medicine, Lexington, Kentucky, USA.
Lucas
B
B
Waid
T
T
McKeown
W
W
Tsuchida
M
M
Thompson
J
J
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D016207:Cytokines / Q000096:biosynthesis; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007371:Interferon-gamma / Q000096:biosynthesis; D007376:Interleukin-2 / Q000096:biosynthesis; D015850:Interleukin-6 / Q000096:biosynthesis; D016030:Kidney Transplantation / Q000276:immunology*; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology*; D014184:Transplantation, Homologous; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis
D000911:Antibodies, Monoclonal; D016207:Cytokines; D007376:Interleukin-2; D015850:Interleukin-6; D016853:Muromonab-CD3; D016693:Receptors, Antigen, T-Cell, alpha-beta; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma